Webinar : How is COVID Revolutionizing Pharma Project Management

UCB and PMI Belgium Chapter welcome you to this webinar:

"How is COVID Revolutionizing Pharma Project Management"
Presentation by speakers from UCB and other pharmaceutical companies

In the 21st, century we have seen technological revolution that has catalyzed the need for companies to enable more agile and rapid transformations across all fronts. Moreover, the COVID-19 pandemic has been disruptive leading to unprecedented challenges and opportunities to organizations.

Why is it that some companies thrive in uncertainty, while others lag behind? What organizational capabilities give successful companies the upper hand? How has project management contributed to the competitive advantage?

This event asks our participants: ‘How did COVID revolutionize the way you work with projects and teams?’

Through presentations and an interactive panel discussion the objective of the event is to provide industry-specific insights, share best practices, and alternative views  on the “new normal” in project management.

This event is a joint effort of UCB, PIPMG (Pharmaceutical Industry Project Management Group) and PMI Belgium Chapter

Welcome and Introduction by PMI

-PMI Belgium Chapter

-Sunil Prashara, CEO PMI

Keynote Speaker:

-Dhaval Patel, Chief Scientific Officer (EVP), UCB

Three Speakers from the pharma industry (15 mins each with a presentation).

Moderator: Gordon Topping, Head of R&D Project and Program Management

-Salman Saif, UCB

-Denise Moody, AstraZeneca

-Mike Palladino, Bristol-Myers Squibb

Q&A Panel (Speakers + Moderator)

End of webinar